Drug Firms Capitalize on 'Male Menopause' Theory
Testosterone prescriptions booming, but medical community is split
By John Johnson,  Newser Staff
Posted Oct 5, 2010 3:52 PM CDT
Suffering from 'manopause'?   (AP)

(Newser) – The concept of a "male menopause" remains controversial in medical circles, but there's no denying its marketing appeal: Pharmaceutical companies are heavily pushing treatments for low testosterone, and the number of middle-aged men receiving prescriptions has jumped from 2.4 million in 2005 to 3.9 million in 2009, reports the Washington Post. One urologist estimates that 5 million American men are afflicted with the telltale symptoms of low libido, mood swings, and even hot flashes.

"It's not as dramatic or as abrupt a change as is often the case in women, but there is this subtle shift in hormone levels that can result, over time, in a man crossing a threshold where he then has a deficit of testosterone," he tells the Post. Skeptics, however, say that all of the problems can be chalked up to normal aging and that the "low-T" scare will prompt unnecessary screenings and treatments. "'Male menopause' is a loaded term, " says an endocrinologist. "It's got so much baggage, this idea that there's this condition that is somehow equivalent to the female menopause."
 

My Take on This Story
Show results without voting  |  
55%
14%
21%
3%
0%
7%